Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,756 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a Candidate 11C-Labeled Selective Phosphodiesterase 1 Radioligand for Positron Emission Tomography.
Rong J, Yamasaki T, Chen J, Kumata K, Zhao C, Fujinaga M, Hu K, Mori W, Zhang Y, Xie L, Chaudhary AF, Zhou X, Zhang W, Gao Y, Zhang K, Patel JS, Song Z, Collier TL, Yuan H, Ran C, Haider A, Li Y, Zhang MR, Liang S. Rong J, et al. Among authors: yamasaki t. ACS Omega. 2024 Oct 21;9(44):44154-44163. doi: 10.1021/acsomega.4c03214. eCollection 2024 Nov 5. ACS Omega. 2024. PMID: 39524622 Free PMC article.
Effect of Baseline Values of Renal Prognosis-related Factors on Their Changes after Initiating Tofogliflozin Treatment: A Retrospective Study in Japanese Patients with Type 2 Diabetes and Renal Impairment.
Matsumoto S, Ito H, Inoue H, I C, Miura S, Antoku S, Yamasaki T, Mori T, Togane M. Matsumoto S, et al. Among authors: yamasaki t. JMA J. 2024 Oct 15;7(4):571-579. doi: 10.31662/jmaj.2024-0128. Epub 2024 Sep 6. JMA J. 2024. PMID: 39513071 Free PMC article.
Combination Assay of Methylated HOXA1 with Tumor Markers Shows High Sensitivity for Detection of Early-Stage Hepatocellular Carcinoma.
Kunimune Y, Suehiro Y, Saeki I, Yamauchi Y, Tanabe N, Matsumoto T, Higaki S, Fujii I, Suzuki C, Okayama N, Nishioka M, Ichihara K, Nagano H, Sakaida I, Takami T, Yamasaki T. Kunimune Y, et al. Among authors: yamasaki t. Liver Cancer. 2024 Feb 14;13(5):487-497. doi: 10.1159/000536211. eCollection 2024 Oct. Liver Cancer. 2024. PMID: 39435267 Free PMC article.
Regulation of human GnT-IV family activity by the lectin domain.
Osada N, Nagae M, Yamasaki T, Harduin-Lepers A, Kizuka Y. Osada N, et al. Among authors: yamasaki t. Carbohydr Res. 2024 Oct 2;545:109285. doi: 10.1016/j.carres.2024.109285. Online ahead of print. Carbohydr Res. 2024. PMID: 39369636
Corrigendum to "Anti-tumor effect of antibody-drug conjugate targeting cell adhesion molecule 1 on GIST cells representing small intestinal GIST" [Experimental and Molecular Pathology 139 (2024) 104922].
Yoshida M, Yuan J, Kihara T, Kimura N, Yamasaki T, Ohkouchi M, Hashikura Y, Isozaki K, Hagiyama M, Ito A, Hirota S. Yoshida M, et al. Among authors: yamasaki t. Exp Mol Pathol. 2024 Sep 24:104934. doi: 10.1016/j.yexmp.2024.104934. Online ahead of print. Exp Mol Pathol. 2024. PMID: 39322523 Free article. No abstract available.
Alpha-fetoprotein and des-gamma-carboxy prothrombin can predict the objective response of patients with hepatocellular carcinoma receiving durvalumab plus tremelimumab therapy.
Saeki I, Shimose S, Tomonari T, Ito T, Tani J, Takeuchi Y, Yoshioka N, Naito T, Takeuchi M, Kakizaki S, Hatanaka T, Sasaki K, Yasunaka T, Sakata M, Iwamoto H, Itano S, Shirono T, Tanabe N, Yamamoto T, Kanayama Y, Naganuma A, Nishina S, Otsuka M, Kobara H, Kawashima H, Takayama T, Kawaguchi T, Yamasaki T, Takami T; Hepatology InVestigator Experts in Japan (HIVE-J) Study Group. Saeki I, et al. Among authors: yamasaki t. PLoS One. 2024 Sep 25;19(9):e0311084. doi: 10.1371/journal.pone.0311084. eCollection 2024. PLoS One. 2024. PMID: 39321197 Free PMC article.
Real-world assessment of comprehensive genome profiling impact on clinical outcomes: A single-institution study in Japan.
Kunimasa K, Sugimoto N, Yamasaki T, Kukita Y, Fujisawa F, Inoue T, Yamaguchi Y, Kitasaka M, Sakai D, Honma K, Wakamatsu T, Yamamoto S, Hayashi T, Mabuchi S, Okuno J, Kawamura T, Kai Y, Urabe M, Nishimura K. Kunimasa K, et al. Among authors: yamasaki t. Cancer Med. 2024 Sep;13(18):e70249. doi: 10.1002/cam4.70249. Cancer Med. 2024. PMID: 39315676 Free PMC article.
1,756 results